-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MpTNPg4ICXiE/UkF+6xljE3CLnFwpd4sRvve9ZODVVrMD2mObcAA2R9PN/EJUMVW qqIsJCL1wdEUM2Oi1YKrJA== 0000950129-07-005933.txt : 20080410 0000950129-07-005933.hdr.sgml : 20080410 20071203184056 ACCESSION NUMBER: 0000950129-07-005933 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 CORRESP 1 filename1.htm corresp
 

[LEXICON PHARMACEUTICALS LETTERHEAD]
December 3, 2007
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
         
Attention:   Mr. Mark Brunhofer
    Division of Corporate Finance
       
 
    Re:  
Lexicon Pharmaceuticals, Inc.
Form 10-K for the fiscal year ended December 31, 2006
Form 10-Q for the quarterly period ended September 30, 2007
File No. 000-30111
Dear Mr. Brunhofer:
     We are in receipt of the comment letter dated November 16, 2007 from the Securities and Exchange Commission’s staff with respect to the above-referenced filings. We are currently preparing our responses to those comments and respectfully request an additional 10 business days within which to provide you with those responses.
     Please contact me at (281) 863-3321 if you are unable to grant this requested extension or if you have any additional comments or questions concerning this letter.
         
  Very truly yours,
 		  
  /s/ Jeffrey L. Wade
 		  
  Jeffrey L. Wade   
  Executive Vice President and
General Counsel 		  
 

-----END PRIVACY-ENHANCED MESSAGE-----